E-assisted Follow up Diagnosis of Post Operative Digestive Complications (SURGICONNECT)

April 18, 2023 updated by: Hospices Civils de Lyon

Impact of E-assisted Connected Follow up on the Delay of Management of Postoperative Complications in Digestive Surgery

Postoperative management in digestive surgery has been modernized thanks to improved rehabilitation measures. These measures include an earlier refeeding, mobilization, restriction of infusions (out of a total of 22) and showed their benefit in colorectal, gastric and bariatric surgery. It is thus possible to perform sleeve gastrectomy, bypass, restorations of digestive continuity and colectomies with early discharge or one day surgery.

The most serious complications (fistula, sepsis) occur in the first 10 days postoperatively with an average readmission rate of 10%. Their screening is based on clinical signs (tachycardia, pain) or biological (C-Reactive Protein (CRP) assay on Day 3 or Day 4). It is important to manage these complications early so that their morbidity is lower, resulting in shorter stays and less severity.

The monitoring and safety of patients discharged early are therefore essential and for the moment poorly codified, ranging from simple nursing to follow-up via a health provider. Recently, coordination structures including nurse platform and smartphone follow up app have emerged. Thanks to this system, the patient collects his own history and biological results which allows him to be monitored continuously, as in the hospital. In case of no filling or sign of complication, the nurse platform contacts the patient.

This connected follow-up would make it possible to reinforce the safety of the patient discharged early after a complex digestive procedure performed on an outpatient basis. Its benefit has been poorly evaluated but it is however more and more used by surgeons convinced of its interest especially as it goes in the direction of the development of the outpatient activity requested by the High Authority of Health with economic benefits interesting also the administration of the care structures.

The purpose of the investigator's study is to evaluate the impact of e-assessed follow-up during 10 days after surgery compared to a conventional follow-up. The hypothesis is that this connected follow-up would allow earlier detection of complications requiring rehospitalization (within 48 hours), resulting in faster and less severe treatment.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

340

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Clermont-Ferrand, France, 63003
        • Withdrawn
        • Service de Chirurgie Digestive, Hôpital d'Estaing, CHU de Clermont-Fd
      • Dijon, France, 21000
        • Withdrawn
        • Service de Chirurgie Digestive, Hôpital Le Bocage, CHU Dijon
      • Grenoble, France, 38043
        • Recruiting
        • Département de Chirurgie Digestive, Hôpital Michallon, CHU Grenoble
        • Contact:
          • Jean-Luc FAUCHERON, MD
        • Principal Investigator:
          • Jean-Luc FAUCHERON, MD
      • Le Puy en Velay, France, 43012
        • Recruiting
        • Service de Chirurgie Viscérale et Digestive, CH Emile Roux
        • Contact:
          • Luis Matias BRUNAS, MD
        • Principal Investigator:
          • Luis Matias BRUNAS, MD
      • Lyon, France, 69004
        • Recruiting
        • Service de Chirurgie Générale, Digestive et de la Transplantation Hépatique, Hôpital de la Croix Rousse, Hospices Civils de Lyon
        • Contact:
          • Kayvan MOHKAM, MD
        • Principal Investigator:
          • Kayvan MOHKAM, MD
      • Lyon, France, 69437
        • Recruiting
        • Service de Chirurgie Digestive, Hôpital Edouard Herriot, Hospices Civils de Lyon
        • Contact:
        • Principal Investigator:
          • Arnaud PASQUER, MD
      • Pierre-Bénite, France, 69310
        • Recruiting
        • Service de Chirurgie Digestive, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon
        • Contact:
          • Eddy COTTE, MD
      • Saint-Étienne, France, 42055
        • Recruiting
        • Service de Chirurgie Digestive et Oncologie Digestive, Hôpital Nord, CHU Saint-Etienne
        • Contact:
          • Bertrand LE ROY, MD
        • Principal Investigator:
          • Bertrand LE ROY, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient, male or female, age ≥18 years
  • Patient hospitalized for colorectal, gastric or bariatric surgery
  • Patient for whom an outpatient or enhanced recovery after surgery is performed (expected discharge no later than 4 days after surgery)
  • Patient with a computer, tablet or mobile connected to internet
  • Patient who agrees to be included in the study and who signs the informed consent form,
  • Patient affiliated with a healthcare insurance plan.

Exclusion Criteria:

  • Minor patient
  • Patient who does not understand French, under supervision or guardianship
  • Mentally unbalanced patients or unable to follow the instructions of a connected follow-up, from the point of view of the investigator
  • Patient who is unable to give consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: E-assessed follow up
Patients undergoing colorectal surgery (colectomy, sigmoidectomy, proctectomy, digestive stoma closure), bariatric or gastric, for whom an early discharge has been programmed, and followed by a connected application and a nursing logistics platform at home.

Clinical questionnaire: self-evaluation of pain (0 to 10), resumption of transit, bleeding, fever, pulse. In case of no filling, the patient is contacted.

An automatic alert system is defined and divide the patient according to three situations:

  • Normal situation
  • Situation requiring the nurse to call back the patient and contact the surgeon if the assessment requires medical advice
  • Disturbing situation requiring contact of the first-line surgeon if a potentially serious event is suspected. Each speaker's place is described for each item in the detailed protocols

Biological questionnaire:

Biological monitoring (blood count, Ionogram, C-Reactive Protein, urea, creatinine) is performed on D1, D3 and D7.

All information is accessible in real time by the surgeon who receives notifications by email and on his smartphone in case of clinical or biological abnormality on patient monitoring.

Other: Standard home follow-up care
Patients undergoing surgery for colorectal surgery (colectomy, sigmoidectomy, proctectomy, digestive stoma closure), bariatric or gastric surgery, for whom an early discharge has been programmed, and followed by usual way.

An information sheet on the clinical parameters to be monitored will be given to patients and will include the following information:

  1. Immediate complications and warning signs:

    • Tachycardia> 120 bpm
    • Dyspnea
    • Rectorragies and / or melena
    • Vomiting with or without presence of blood
    • Major abdominal pain (visual analogue scale> 6/10)
    • Fever> 38
  2. Management to deal with complications: call the service and / or the surgeon
  3. Actions to be performed by the patient after the exit:passage of the nurse during 10 days for anticoagulant morning and evening (identical in both study groups)

Each patient will be given a prescription to perform a C-Reactive Protein assay on D1, D3 and D7, similarly.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time required for the management of post-operative complications requiring rehospitalization
Time Frame: Within 6 months after surgery
Number of hours between discharge from hospitalization after digestive surgery and readmission for hospitalization during which medical, surgical, radiological or endoscopic treatment is performed.
Within 6 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severe postoperative complication rate
Time Frame: Within 30 days after surgery

Rate of medical and surgical (> or = grade 3) complications within 30 days after surgery using the Dindo-Clavien classification, described as:

Grade I = Any deviation from the normal postoperative course. Grade 2 = Requiring pharmacological treatment with drugs other than such allowed for grade I complications.

Grade III = Requiring surgical, endoscopic or radiological intervention, not under (Grade IIIa) or under general anesthesia (Grade IIIb) Grade IV = Life-threatening complication with single organ (Grade IVa) or Multiorgan dysfunction (Grade IVb) Grade V = Death of a patient.

Within 30 days after surgery
Early overall complication rate
Time Frame: Within 30 days after surgery
Rate of medical and surgical complications (each grade) within 30 days after surgery using the Dindo-Clavien classification
Within 30 days after surgery
Type of early complications
Time Frame: Within 30 days after surgery
Type (medical or surgical) of late complications (after 30 days) for each procedure according to the Dindo-Clavien classification
Within 30 days after surgery
Severity of early complications
Time Frame: Within 30 days after surgery
Severity of late complications (after 30 days) for each procedure according to the Dindo-Clavien classification
Within 30 days after surgery
Late overall complication rate
Time Frame: Within 6 months after surgery
Rate of medical and surgical complications (each grade) within 6 months after surgery using the Dindo-Clavien classification
Within 6 months after surgery
Type of late complications
Time Frame: Within 6 months after surgery
Type (medical or surgical) of late complications (after 6 months) for each procedure according to the Dindo-Clavien classification
Within 6 months after surgery
Severity of late complications
Time Frame: Within 6 months after surgery
Severity of late complications (after 6 months) for each procedure according to the Dindo-Clavien classification
Within 6 months after surgery
Postoperative mortality
Time Frame: Within 30 days and 6 months after surgery
Number of patients who died within 30 days and 6 months after surgery
Within 30 days and 6 months after surgery
Readmission of patient
Time Frame: Within 30 days and 6 months after surgery
Number of patients readmitted within 30 days and 6 months after surgery.
Within 30 days and 6 months after surgery
Quality of life assessed with SF36 questionnaire
Time Frame: Before surgery and at 10 and 30 days after surgery

Before surgery and at 10 and 30 days after surgery, according to the SF36 (Short Form (36) Health Survey) questionnaire.

This questionnaire taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/tiredness, and general health perceptions. It also includes a single item that provides an indication of a perceived change in health.

Before surgery and at 10 and 30 days after surgery
Quality of life assessed with GIQLI questionnaire
Time Frame: Before surgery and at 10 and 30 days after surgery

Before surgery and at 10 and 30 days after surgery, according to the GIQLI (Gastrointestinal Quality of Life index) questionnaire.

This questionnaire consists of 36 items exploring 5 dimensions or subscales: symptoms, physical condition, emotions, social integration and the effect of any medical treatment. For each item, 5 responses will be proposed to the patients and for each answer, a score ranging from 0 to 4 (highest score = 144) will be assigned. A high score defines a more favorable health state.

Before surgery and at 10 and 30 days after surgery
Patient satisfaction: VAS
Time Frame: 10 days after surgery
Satisfaction will be measured using a visual analog scale, rated from 0 (no satisfaction) to 10 (Perfect Satisfaction)
10 days after surgery
Patient sense of security
Time Frame: 10 days after surgery
Sence of security will be measured using a visual analog scale, rated from 0 (no security felt) to 10 (Complete security felt Satisfaction)
10 days after surgery
Costs
Time Frame: 7 months post-inclusion
Costs associated with the strategy including the Follow-up care via Mobile App compared to the standard follow-up care strategy.
7 months post-inclusion
Consequences
Time Frame: 7 months post-inclusion
Consequences associated with the strategy including the Follow-up care via Mobile App compared to the standard follow-up care strategy.
7 months post-inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 23, 2020

Primary Completion (Anticipated)

December 23, 2023

Study Completion (Anticipated)

December 23, 2023

Study Registration Dates

First Submitted

May 15, 2019

First Submitted That Met QC Criteria

May 20, 2019

First Posted (Actual)

May 21, 2019

Study Record Updates

Last Update Posted (Actual)

April 19, 2023

Last Update Submitted That Met QC Criteria

April 18, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-operative Complications After Colorectal Surgery

Clinical Trials on E-assessed clinical and biological follow up

3
Subscribe